Corrigendum to “Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents” (Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents (2011) 19(18) (5409–5419), (S0968089611006183), (10.1016/j.bmc.2011.07.056));Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents

Bioorganic and Medicinal Chemistry

Volumn 19, Issue 18, 2011, Pages 5409-5419

  Kumar, Atul ^a   Tripathi, Vishwa Deepak ^a   Kumar, Promod ^a   Gupta, Lalit Prakash ^a   Akanksha, ^a   Trivedi, Ritu ^a   Bid, Hemant ^a   Nayak, V L ^a   Siddiqui, Jawed A ^a   Chakravarti, Bandana ^a   Saxena, Ruchi ^a   Dwivedi, Anila ^a   Siddiquee, M I ^a   Siddiqui, U ^a   Konwar, Rituraj ^a   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Anti breast cancer; Anti implantation; Osteoporosis; Raloxifene; SERM

Indexed keywords

1 (4 CHLOROPHENYL) 3 (4 CHLOROPHENYLSULFANYL) 3 PHENYL PROPAN 1 ONE; 1 (4 CHLOROPHENYL) 3 (4 METHOXYPHENYL) 3 (PHENYLTHIO)PROPAN 1 ONE; 1 (4 HYDROXYPHENYL) 3 PHENYL 3 (PHENYLTHIO)PROPAN 1 ONE; 1,3 BIARYLSULFANYL DERIVATIVE; 1,3 BIS (4 METHOXY PHENYL) 3 4 TOLYL SULFANYL PROPAN 1 ONE; 1,3 BIS (4 METHOXY PHENYL) 3 PHENYLSULFANYL PROPAN 1 ONE; 1,3 DIPHENYL 3 4 TOLYLSULFANYL PROPAN 1 ONE; 1,3 DIPHENYL 3 PHENYLSULFANYL PROPAN 1 ONE; 3 (4 CHLORO PHENYL SULFANYL) 1,3 DIPHENYL PROPAN 1 ONE; 3 (4 CHLOROPHENYLTHIO) 1 (4 METHOXYPHENYL) 3 PHENYLPROPAN 1 ONE; 3 (4 CHLOROPHENYLTHIO) 1 (4 NITROPHENYL) 3 PHENYLPROPAN 1 ONE; 3 (4 HYDROXYPHENYL) 1 PHENYL 3 (3 TOLYLTHIO)PROPAN 1 ONE; 3 (4 HYDROXYPHENYL) 1 PHENYL 3 (PHENYLTHIO)PROPAN 1 ONE; 3 (4 HYDROXYPHENYL) 3 4 TOLYL 3 (4 TOLYLTHIO)PROPAN 1 ONE; 3 (4 METHOXYPHENYL) 1 PHENYL 3 (4 TOLYLTHIO)PROPAN 1 ONE; 3 (4 METHOXYPHENYL) 1 PHENYL 3 (PHENYLTHIO)PROPAN 1 ONE; 3 ETHYL 4,4' (4 HYDROXYPHENETHYL)PHENOL; 4,4' (HEXANE 1,3 DIYL)DIPHENOL; 4,4' (HEXANE 1,6 DIYL)DIPHENOL; ACOLBIFENE; ANTINEOPLASTIC AGENT; ARZOXIFENE; DIENSTROL; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; HEXESTROL; RALOXIFENE; TRIOXIFENE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG DESIGN; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; RAT; TREATMENT RESPONSE;

EID: 80052577430     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2019.07.018     Document Type: Erratum

References (21)

1. A.M. Coley Cancer Treat. Rev. 34 2008 378
2. American Cancer Society. Breast Cancer Facts & Figures 2007-2008; American Cancer Society: Atlanta, GA, 2007.
3. V.C. Jordan, and W. Gradishar J. Mol. Aspect Med. 18 1997 187
4. A.G. Timothy, S. Cho, D.R. Finley, A. Godfrey, C.D. Jones, C.W. Lugar III, M.J. Martin, K. Matsumoto, L.D. Pennington, M.A. Winter, M.D. Adrian, H.W. Cole, D.E. Magee, D.L. Phillips, E.R. Rowley, L.L. Short, A.L. Glasebrook, and H.U. Bryant J. Med. Chem. 40 1997 146
5. J.E. Compston Physiol. Rev. 81 2001 419
6. C. Carani, K. Qin, M. Simoni, M. Faustini-Fustini, S. Serpente, J. Boyd, K.S. Korach, and E.R.N. Simpson N. Eng. J. Med. 337 1997 91
7. Lyndsay, R. B. L.; Melton, L. G., Eds.; Osteoporosis: Etiology, Diagnosis, and Management; Raven: New York, 1988; p 333.
8. R.K. Ross, M.C. Pike, T.M. Mack, and B.E. Henderson J.O. Drife, J.W.W. Studd, HRT and Osteoporosis 1990 Springer-Verlag London 209
9. J.E. Compston Lancet 350 1997 676
10. L.J. Lerner, and V.C. Jordan Cancer Res. 50 1990 4177
11. M. Marric, and O. Gluck Opin. Pharmacother. 3 2002 767
12. R.J. Santen, J. Pinkerton, C. Mecartney, and G.R. Petroni J. Clin. Endocrinol. Metab. 86 2001 16
13. Y. Shang, and M. Brown Science 24 2002 145
14. N.A. Sims, S. Dupont, A. Krust, Minet. D. Clement-Lacroix, M. Resche Rigon, M. Gaillard-Kelly, and R. Baron Bone. 30 2002 18
15. V.C. Jordan Nat. Rev. Drug Disc. 2 2003 205
16. A.D. Palkowitz, A.L. Glasebrook, K.J. Thrasher, K.L. Hauser, L.L. Short, D.L. Phillips, B.S. Muehl, M. Sato, P.K. Shetler, G.J. Cullinan, T.R. Pell, and H.U. Bryant J. Med. Chem. 40 1997 1407
17. J.S. Lewis, and V.C. Jordan Mutat. Res. 591 2005 247
18. J.B. Drakulic, Z.D. Juranic, T.P. Stanojkovic, and I.O. Juranic J. Med. Chem. 48 2005 5600
19. S. Sarkhel, A. Sharon, V. Trivedi, P.R. Maulik, M.M. Singh, P. Venugopalan, and S. Ray Bioorg. Med. Chem. 11 2003 5025
20. G.A. Patani, and E. Lavoie J. Chem. Rev. 96 1996 3147
21. L.M. Greenberger, T. Annable, K.I. Collins, B.S. Komm, C.R. Lyttle, C.P. Miller, P.G. Satyaswaroop, Y. Zhang, and P. Frost Clin. Cancer Res. 7 2001 3166